{
    "Trade/Device Name(s)": [
        "ADVIA Centaur CMV IgG",
        "ADVIA Centaur CMV IgG Quality Control"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics, Inc.",
    "510(k) Number": "K181213",
    "Predicate Device Reference 510(k) Number(s)": [
        "K920661"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFZ",
        "QCH"
    ],
    "Summary Letter Date": "May 1, 2018",
    "Summary Letter Received Date": "May 7, 2018",
    "Submission Date": "May 1, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.3175"
    ],
    "Regulation Name(s)": [
        "Cytomegalovirus serological reagents"
    ],
    "Analyte Class(es)": [
        "immunology",
        "microbiology",
        "virology",
        "serology"
    ],
    "Analyte(s)": [
        "Cytomegalovirus IgG antibodies"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (dipotassium EDTA, lithium heparin)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur XP system"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Indirect chemiluminometric sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Quality Control",
        "Calibrator",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens ADVIA Centaur CMV IgG immunoassay and quality control for qualitative detection of cytomegalovirus IgG antibodies in human serum and plasma.",
    "Indications for Use Summary": "Qualitative detection of IgG antibodies to cytomegalovirus in pediatric and adult human serum and plasma (dipotassium EDTA, lithium heparin) as an aid in determining CMV serological status and diagnosing CMV infection; not for blood or tissue donor screening.",
    "fda_folder": "Microbiology"
}